Safety and efficacy of everolimus in Chinese patients with metastatic renal cell carcinoma resistant to vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy: an open-label phase 1b study

Peer Review reports

Original Submission
18 Sep 2012	Submitted	Original manuscript
26 Sep 2012	Author responded	Author comments - Jun Guo
Resubmission - Version 2
26 Sep 2012	Submitted	Manuscript version 2
26 Nov 2012	Reviewed	Reviewer Report - Brian Rini
10 Dec 2012	Reviewed	Reviewer Report - Ronald Bukowski
18 Jan 2013	Author responded	Author comments - Jun Guo
Resubmission - Version 3
18 Jan 2013	Submitted	Manuscript version 3
Publishing
11 Mar 2013	Editorially accepted
21 Mar 2013	Article published	10.1186/1471-2407-13-136

Back to article page